deferiprone has been researched along with Nervous System Disorders in 2 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Economou, M | 1 |
| Teli, A | 1 |
| Gourtsa, V | 1 |
| Vargiami, E | 1 |
| Zafeiriou, D | 1 |
| Taher, A | 1 |
| Sheikh-Taha, M | 1 |
| Koussa, S | 1 |
| Inati, A | 1 |
| Neeman, R | 1 |
| Mourad, F | 1 |
1 trial available for deferiprone and Nervous System Disorders
| Article | Year |
|---|---|
Comparison between deferoxamine and deferiprone (L1) in iron-loaded thalassemia patients.
Topics: Administration, Oral; Adolescent; Adult; beta-Thalassemia; Chelation Therapy; Child; Deferiprone; De | 2001 |
1 other study available for deferiprone and Nervous System Disorders
| Article | Year |
|---|---|
Neurological Involvement in a Thalassemic Child Receiving Deferiprone.
Topics: Child; Deferiprone; Female; Humans; Iron Chelating Agents; Nervous System Diseases; Pyridones; Thala | 2016 |